Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1521

1.

[Management of Patients with CKD in Clinical Practice].

Dabers T, Weckmann G, Chenot JF, Stracke S.

Dtsch Med Wochenschr. 2017 Sep;142(17):1290-1298. doi: 10.1055/s-0043-108466. Epub 2017 Aug 29. German.

PMID:
28850966
2.

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.

Navar AM, Gallup DS, Lokhnygina Y, Green JB, McGuire DK, Armstrong PW, Buse JB, Engel SS, Lachin JM, Standl E, Van de Werf F, Holman RR, Peterson ED; TECOS Study Group.

Hypertension. 2017 Nov;70(5):907-914. doi: 10.1161/HYPERTENSIONAHA.117.09482. Epub 2017 Aug 28.

PMID:
28847886
3.

Paratubular basement membrane insudative lesions predict renal prognosis in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.

Mise K, Yamaguchi Y, Hoshino J, Ueno T, Sekine A, Sumida K, Yamanouchi M, Hayami N, Suwabe T, Hiramatsu R, Hasegawa E, Sawa N, Fujii T, Hara S, Sugiyama H, Makino H, Wada J, Ohashi K, Takaichi K, Ubara Y.

PLoS One. 2017 Aug 15;12(8):e0183190. doi: 10.1371/journal.pone.0183190. eCollection 2017.

4.

Annual deterioration of renal function in hypertensive patients with and without diabetes.

Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S.

Vasc Health Risk Manag. 2017 Jun 26;13:231-237. doi: 10.2147/VHRM.S135253. eCollection 2017.

5.

Diabetes Update: Prevention and Management of Diabetes Complications.

Choby B.

FP Essent. 2017 May;456:36-40. Review.

PMID:
28530383
6.

Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.

Muntner P, Whelton PK.

J Am Coll Cardiol. 2017 May 16;69(19):2446-2456. doi: 10.1016/j.jacc.2017.02.066. Review.

PMID:
28494981
7.

Oleuropein improves glucose tolerance and lipid profile in rats with simultaneous renovascular hypertension and type 2 diabetes.

Khalili A, Nekooeian AA, Khosravi MB.

J Asian Nat Prod Res. 2017 Oct;19(10):1011-1021. doi: 10.1080/10286020.2017.1307834. Epub 2017 Mar 28.

PMID:
28347166
8.

The effects of dual PPAR<i>α</i>/<i>γ</i> agonism compared with ACE inhibition in the BTBRob/ob mouse model of diabetes and diabetic nephropathy.

Ericsson A, Tonelius P, Lal M, Sabirsh A, Böttcher G, William-Olsson L, Strömstedt M, Johansson C, Hyberg G, Tapani S, Jönsson-Rylander AC, Unwin R.

Physiol Rep. 2017 Mar;5(5). pii: e13186. doi: 10.14814/phy2.13186.

9.

Social disparities in diabetes care: a general population study in Denmark.

Heltberg A, Andersen JS, Kragstrup J, Siersma V, Sandholdt H, Ellervik C.

Scand J Prim Health Care. 2017 Mar;35(1):54-63. doi: 10.1080/02813432.2017.1288702. Epub 2017 Mar 3.

10.

Optimal Systolic Blood Pressure Levels for Primary Prevention of Stroke in General Hypertensive Adults: Findings From the CSPPT (China Stroke Primary Prevention Trial).

Fan F, Yuan Z, Qin X, Li J, Zhang Y, Li Y, Yu T, Ji M, Ge J, Zheng M, Yang X, Bao H, Cheng X, Gu D, Zhao D, Wang J, Sun N, Chen Y, Wang H, Wang X, Parati G, Hou F, Xu X, Wang X, Zhao G, Huo Y.

Hypertension. 2017 Apr;69(4):697-704. doi: 10.1161/HYPERTENSIONAHA.116.08499. Epub 2017 Feb 27.

PMID:
28242714
11.

Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).

Bress AP, Kramer H, Khatib R, Beddhu S, Cheung AK, Hess R, Bansal VK, Cao G, Yee J, Moran AE, Durazo-Arvizu R, Muntner P, Cooper RS.

Circulation. 2017 Apr 25;135(17):1617-1628. doi: 10.1161/CIRCULATIONAHA.116.025322. Epub 2017 Feb 13.

PMID:
28193605
13.
14.

Comparative Efficacy and Safety of Antihypertensive Agents for Adult Diabetic Patients with Microalbuminuric Kidney Disease: A Network Meta-Analysis.

Huang R, Feng Y, Wang Y, Qin X, Melgiri ND, Sun Y, Li X.

PLoS One. 2017 Jan 3;12(1):e0168582. doi: 10.1371/journal.pone.0168582. eCollection 2017.

15.

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.

Uzu T, Araki SI, Kashiwagi A, Haneda M, Koya D, Yokoyama H, Kida Y, Ikebuchi M, Nakamura T, Nishimura M, Takahara N, Obata T, Omichi N, Sakamoto K, Shingu R, Taki H, Nagai Y, Tokuda H, Kitada M, Misawa M, Nishiyama A, Kobori H, Maegawa H; Shiga Committee for Preventing Diabetic Nephropathy.

PLoS One. 2016 Dec 29;11(12):e0164936. doi: 10.1371/journal.pone.0164936. eCollection 2016.

16.

Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.

Saulnier PJ, Gand E, Velho G, Mohammedi K, Zaoui P, Fraty M, Halimi JM, Roussel R, Ragot S, Hadjadj S; SURDIAGENE Study Group.

Diabetes Care. 2017 Mar;40(3):367-374. doi: 10.2337/dc16-1571. Epub 2016 Dec 20.

PMID:
27998909
17.
18.

A Survey of Actual Clinical Practice Concerning Blood Pressure Control among Patients with Hypertension in Kanagawa 2014.

Hatori N, Sakai H, Sato K, Miyajima M, Yuasa S, Kuboshima S, Kajiwara K, Hara Y, Minamizawa K, Miyakawa M.

J Nippon Med Sch. 2016;83(5):188-195.

19.

Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes.

Ku E, McCulloch CE, Mauer M, Gitelman SE, Grimes BA, Hsu CY.

Diabetes Care. 2016 Dec;39(12):2218-2224.

20.

Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.

Brunström M, Eliasson M, Nilsson PM, Carlberg B.

J Hypertens. 2017 Mar;35(3):453-462. doi: 10.1097/HJH.0000000000001183. Review.

PMID:
27870655

Supplemental Content

Loading ...
Support Center